Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,999 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A multi-institutional feasibility study of S-1/oxaliplatin plus bevacizumab in patients with advanced/metastatic colorectal cancer: the HiSCO-02 prospective phase II study.
Shimomura M, Shinozaki K, Hinoi T, Yoshimitsu M, Kurayoshi M, Sumitani D, Ishizaki Y, Oshiro T, Kodama S, Shimizu Y, Arita M, Tokunaga M, Yoshida M, Tanaka J, Ohdan H; Hiroshima Surgical study group of Clinical Oncology (HiSCO). Shimomura M, et al. Among authors: shimizu y. Springerplus. 2016 Oct 18;5(1):1800. doi: 10.1186/s40064-016-3491-8. eCollection 2016. Springerplus. 2016. PMID: 27803845 Free PMC article.
A prospective feasibility study of uracil-tegafur and leucovorin as adjuvant chemotherapy for patients aged ≥ 80 years after curative resection of colorectal cancer, the HiSCO-03 study.
Okuda H, Shimomura M, Ikeda S, Nakahara M, Miguchi M, Ishizaki Y, Saitoh Y, Toyota K, Sumitani D, Shimizu Y, Takakura Y, Shimizu W, Yoshimitsu M, Kodama S, Fujimori M, Oheda M, Kobayashi H, Ohdan H; Hiroshima Surgical Study Group of Clinical Oncology (HiSCO). Okuda H, et al. Among authors: shimizu y, shimizu w. Cancer Chemother Pharmacol. 2023 Apr;91(4):317-324. doi: 10.1007/s00280-023-04526-7. Epub 2023 Mar 22. Cancer Chemother Pharmacol. 2023. PMID: 36947210 Clinical Trial.
Predictive factors associated with anastomotic leakage after resection of rectal cancer: a multicenter study with the Hiroshima Surgical study group of Clinical Oncology.
Bekki T, Shimomura M, Adachi T, Miguchi M, Ikeda S, Yoshimitsu M, Kohyama M, Nakahara M, Kobayashi H, Toyota K, Shimizu Y, Sumitani D, Saito Y, Takakura Y, Ishizaki Y, Kodama S, Fujimori M, Hattori M, Shimizu W, Ohdan H. Bekki T, et al. Among authors: shimizu y, shimizu w. Langenbecks Arch Surg. 2023 May 19;408(1):199. doi: 10.1007/s00423-023-02931-3. Langenbecks Arch Surg. 2023. PMID: 37204489
5,999 results